bioRxiv Science⌕ Search

Biology subjects

Neely, C.

Publications and source records attributed to Neely, C..

3 recordsLinked to original sources

Data coherence over data volume drives generalisable genome-based prediction of microbial carbon utilisation

Microbial carbon utilisation is a foundational ecological phenotype that remains difficult to predict from genomes despite well-characterised pathways. Machine-learning models generalise poorly across datasets, a failure usually attributed to training-set size and taxonomic bias. To test this, we integrated binary growth phenotypes for 819 strains across 240 carbon sources from four datasets. Balanced accuracy fell from 0.86 within datasets to 0.62 across them, and testing on close relatives recovered only 0.03 of that drop, so mechanistically inconsistent genotype-phenotype relationships drove models to dataset-correlated shortcuts. Restricting training to concordant samples (measured growth matched their annotated pathway) doubled the carbon sources recovering known pathway genes across datasets (6 to 12 of 15), whereas matched random subsets did not. Adding over 8000 literature-curated BacDive genomes to the training set did not improve cross-dataset performance more than the smaller concordant set, suggesting coherence matters more than volume. Because such filtering requires a mechanistic predictor, we tested a mechanism-free alternative combining phylogenetic agreement and experimental labels, which recovered part of the gain but not the recall advantage. Concordance-trained models were bounded specialists, rescuing mechanistic false negatives twice as often as false positives (44\% versus 19\%), mostly metabolic generalists. To locate those bounds, model confidence defined an applicability domain, and prioritising low-confidence genomes for training improved cross-dataset accuracy more than random or diversity-based sampling, especially for the weaker phenotypes. This recasts generalisation in biological machine learning as a problem of label-mechanism agreement and applicability-domain definition, alongside data volume and algorithm choice.

bioinformatics↗

Estimating the maximal growth rates of eukaryotic microbes from cultures and metagenomes via codon usage patterns

Microbial eukaryotes are ubiquitous in the environment and play important roles in key ecosystem processes, including accounting for a significant portion of global primary production. Yet, our tools for assessing the functional capabilities of eukaryotic microbes in the environment are quite limited because many microbes have yet to be grown in culture. Maximum growth rate is a fundamental parameter of microbial lifestyle that reveals important information about an organisms functional role in a community. We developed and validated a genomic estimator of maximum growth rate for eukaryotic microbes, enabling the assessment of growth potential for organisms and communities directly in the environment. We produced a database of over 700 maximum growth rate predictions from genomes, transcriptomes, and metagenome-assembled genomes. By comparing the maximal growth rates of existing culture collections with environmentally-derived genomes we found that, unlike for prokaryotes, culture collections of microbial eukaryotes are only minimally biased in terms of growth potential. We then extended our tool to make community-wide estimates of growth potential from over 500 marine metagenomes, mapping growth potential across the global oceans. We found that prokaryotic and eukaryotic communities have highly correlated growth potentials near the ocean surface, but there is no correlation in their genomic potentials deeper in the water column. This suggests that fast growing eukaryotes and prokaryotes thrive under similar conditions at the ocean surface, but that there is a decoupling of these communities as resources become scarce deeper in the water column.

microbiology↗

Small Molecule Inhibition of the Innate Immune Response Increases Transgene Expression

Foreign molecules like plasmid DNA trigger a complex and potent innate immune response comprised of highly redundant signal transduction cascades that result in the activation of transcription factors and the production of inflammatory cytokines. Unfortunately, this defense mechanism can hinder gene therapy by inhibiting transgene expression. The goal of this study was to increase transgene expression by inhibiting key components of the innate immune response ({beta}-catenin, NF-{kappa}B/AP1, TBK1, TLR9, and p38 MAPK) with small molecule inhibitors (iCRT-14, curcumin, BX-795, E6446, and VX-702 respectively). The effects of each drug on transgene (luciferase) expression, inflammatory cytokine (IL-6) levels, and cell viability were quantified in prostate (PC3), breast (MCF-7), and murine bladder (MB49) cancer cell lines. The {beta}-catenin inhibitor iCRT-14 (1 M) provided the highest enhancement of 35.5 {+/-} 19-fold in MCF-7 cells, while the other inhibitors increased transgene expression at a more modest level (2-9 fold). The optimal concentrations of iCRT-14, curcumin, and VX-702 showed no significant effect on cell proliferation; however, optimal concentrations of BX-795 and E6446 did significantly reduce cell proliferation. Nonetheless, inhibition of the innate immune response by iCRT-14 and curcumin was confirmed by a concomitant decrease in IL-6 production in PC3 cells. These results demonstrate that these inhibitors can improve gene therapy by preventing an inflammatory innate immune response.

bioengineering↗